Hidradenitis Suppurativa (HS) Clinical Trials


Are you suffering from Hidradenitis Suppurativa (or HS)?

If you are suffering from HS, we are seeking volunteers for participation in one of the following HS clinical trials. At Menter Dermatology Research Institute we are constantly adding new clinical trials to study HS. Check back often or sign up to receive an email regarding future HS clinical trials.

Qualified study participants will receive study drug, related testing, and compensation for their time and travel.

Current HS Clinical Trial:

Clinical Trial Government Identifier #NCT03713619

Sponsor: Novartis

hidradenitis suppurativa

Genders eligible for study: Male/Female Ages eligible for study: 18 and older
NEW STUDY, NOW ENROLLING – HS (hidradenitis suppurativa) present for at least 1 year; at least 5 active lesions in two areas; no prior use of Cosentyx (secukinumab) allowed August 2019 – TBD

Please get in touch if you are interested in participating in the future, even if you do not see a trial that you currently qualify for!